Holger Jentsch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Holger Jentsch has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Hartmut Schneider
Department of Cariology, Endodontology and Periodontology, University of Leipzig, Liebigstraße 12, 04103 Leipzig, Germany
2 shared publications - Matthias Häfer
Department of Cariology, Endodontology and Periodontology, University of Leipzig, Liebigstraße 12, 04103 Leipzig, Germany
2 shared publications - Rainer Haak
Department of Cariology, Endodontology and Periodontology, University of Leipzig, Liebigstraße 12, 04103 Leipzig, Germany
2 shared publications Andreas Fuchß
1 shared publication- Anne-Katrin Koehler
PathoNext GmbH, 04103 Leipzig, Germany
1 shared publication - Catalina-Suzana Stingu
Institute for Medical Microbiology and Virology, University of Leipzig Medical Center, 04103 Leipzig, Germany
1 shared publication
Latest Publications
- Open Access
Comment on Onisor et al. Reply to Stein, J.M. Comment on “Onisor et al. Effectiveness and Clinical Performance of Erythritol Air-Polishing in Non-Surgical Periodontal Therapy: A Systematic Review of Randomized Clinical Trials. Medicina 2022, 58, 866”
We comment on the reply of Onisor et al
Open AccessComment on Onisor et al. Reply to Stein, J.M. Comment on “Onisor et al. Effectiveness and Clinical Performance of Erythritol Air-Polishing in Non-Surgical Periodontal Therapy: A Systematic Review of Randomized Clinical Trials. Medicina 2022, 58, 866”
We comment on the reply of Onisor et al
- Open Access
- 30 December 2022
- Published by MDPI AG in Antibiotics
- Vol. 12 (1) , 68
Relationship between Phenotypic and Genotypic Resistance of Subgingival Biofilm Samples in Patients with Periodontitis
The phenotypic expression of antibiotic resistance genes (ARGs) can hamper the use of antibiotics as adjuncts to subgingival instrumentation in the treatment of periodontitis patients. The aim of the study was to analyze the relationship between the phenotypic and genotypic resistance against ampicillin-sulbactam, clindamycin, doxycycline and metronidazole of subgingival biofilm samples from 19 periodontitis patients. Samples were analyzed with shotgun sequencing and cultivated anaerobically for 7 days on microbiological culture media incorporating antibiotics. All growing isolates were identified to the species level using MALDI-TOF-MS and sequence analysis of the 16S ribosomal RNA (rRNA) gene. Phenotypic resistance was determined using EUCAST-breakpoints. The genetic profile of eight patients matched completely with phenotypical resistance to the tested antibiotics. The positive predictive values varied from 1.00 for clindamycin to 0.57 for doxycycline and 0.25 for ampicillin-sulbactam. No sample contained the nimI gene. It can be concluded that antibiotic resistance may be polygenetic and genes may be silent. Every biofilm sample harboring erm genes was phenotypic resistant. The absence of cfx and tet genes correlated to 100%, respectively, to 75%, with the absence of phenotypic resistance. The absence of nimI genes leads to the assumption that constitutive resistance among several species could explain the resistance to metronidazole.
- 30 December 2022
- Published by MDPI AG in Antibiotics
- Vol. 12 (1) , 68
Open AccessRelationship between Phenotypic and Genotypic Resistance of Subgingival Biofilm Samples in Patients with Periodontitis
The phenotypic expression of antibiotic resistance genes (ARGs) can hamper the use of antibiotics as adjuncts to subgingival instrumentation in the treatment of periodontitis patients. The aim of the study was to analyze the relationship between the phenotypic and genotypic resistance against ampicillin-sulbactam, clindamycin, doxycycline and metronidazole of subgingival biofilm samples from 19 periodontitis patients. Samples were analyzed with shotgun sequencing and cultivated anaerobically for 7 days on microbiological culture media incorporating antibiotics. All growing isolates were identified to the species level using MALDI-TOF-MS and sequence analysis of the 16S ribosomal RNA (rRNA) gene. Phenotypic resistance was determined using EUCAST-breakpoints. The genetic profile of eight patients matched completely with phenotypical resistance to the tested antibiotics. The positive predictive values varied from 1.00 for clindamycin to 0.57 for doxycycline and 0.25 for ampicillin-sulbactam. No sample contained the nimI gene. It can be concluded that antibiotic resistance may be polygenetic and genes may be silent. Every biofilm sample harboring erm genes was phenotypic resistant. The absence of cfx and tet genes correlated to 100%, respectively, to 75%, with the absence of phenotypic resistance. The absence of nimI genes leads to the assumption that constitutive resistance among several species could explain the resistance to metronidazole.
- 21 December 2020
- Published by S. Karger AG
- Vol. 29, 74-79
Actual Concepts for Individual Interdental Biofilm Removal
The intraoral biofilm requires mechanical removal due to its physical properties. When exposed to the biofilm, interdental areas need special devices to be used. The most effective ones and the first choice are interdental brushes. However, they may not be adequate in the case of very narrow interdental spaces. Despite the difficulties in handling, dental floss may have some advantage in subgingival cleaning. Data are present for gingivitis and periodontitis, but almost no information has been published on gingivally healthy individuals. With respect to interdental caries there is evidence that floss only has a protective value when used professionally and without sufficient fluoridation. There are no such data available on interdental brushes.
- 21 December 2020
- Published by S. Karger AG
- Vol. 29, 74-79
Actual Concepts for Individual Interdental Biofilm Removal
The intraoral biofilm requires mechanical removal due to its physical properties. When exposed to the biofilm, interdental areas need special devices to be used. The most effective ones and the first choice are interdental brushes. However, they may not be adequate in the case of very narrow interdental spaces. Despite the difficulties in handling, dental floss may have some advantage in subgingival cleaning. Data are present for gingivitis and periodontitis, but almost no information has been published on gingivally healthy individuals. With respect to interdental caries there is evidence that floss only has a protective value when used professionally and without sufficient fluoridation. There are no such data available on interdental brushes.
- Open Access
- 9 October 2020
- Published by MDPI AG in Antibiotics
- Vol. 9 (10) , 686
Non-Surgical Periodontal Therapy with Adjunctive Amoxicillin/Metronidazole or Metronidazole When No Aggregatibacter actinomycetemcomitans Is Detected—A Randomized Clinical Trial
Background: The aim was to compare two different systemic antibiotics regimens adjunctive to non-surgical periodontal therapy when Aggregatibacter actinomycetemcomitans was not detected in the subgingival biofilm. Methods: A total of 58 patients with periodontitis and with no A. actinomycetemcomitans in the subgingival biofilm were treated with full-mouth subgingival instrumentation and either metronidazole (MET; n = 29) or amoxicillin/metronidazole (AMX/MET; n = 29). Probing depth (PD), clinical attachment level (CAL) and bleeding on probing (BOP) were recorded at baseline, as well as after three and six months. Subgingival biofilm and gingival crevicular fluid were collected and analyzed for major periodontopathogens and biomarkers. Results: PD, CAL and BOP improved at 3 and 6 months (each p < 0.001 vs. baseline) with no difference between the groups. Sites with initial PD ≥ 6 mm also improved in both groups after 3 and 6 months (p < 0.001) with a higher reduction of PD in the AMX/MET group (p < 0.05). T. forsythia was lower in the AMX/MET group after 3 months (p < 0.05). MMP-8 and IL-1β were without significant changes and differences between the groups. Conclusion: When A. actinomycetemcomitans was not detected in the subgingival biofilm, the adjunctive systemic use of amoxicillin/metronidazole results in better clinical and microbiological outcomes of non-surgical periodontal therapy when the application of systemic antibiotics is scheduled.
- 9 October 2020
- Published by MDPI AG in Antibiotics
- Vol. 9 (10) , 686
Open AccessNon-Surgical Periodontal Therapy with Adjunctive Amoxicillin/Metronidazole or Metronidazole When No Aggregatibacter actinomycetemcomitans Is Detected—A Randomized Clinical Trial
Background: The aim was to compare two different systemic antibiotics regimens adjunctive to non-surgical periodontal therapy when Aggregatibacter actinomycetemcomitans was not detected in the subgingival biofilm. Methods: A total of 58 patients with periodontitis and with no A. actinomycetemcomitans in the subgingival biofilm were treated with full-mouth subgingival instrumentation and either metronidazole (MET; n = 29) or amoxicillin/metronidazole (AMX/MET; n = 29). Probing depth (PD), clinical attachment level (CAL) and bleeding on probing (BOP) were recorded at baseline, as well as after three and six months. Subgingival biofilm and gingival crevicular fluid were collected and analyzed for major periodontopathogens and biomarkers. Results: PD, CAL and BOP improved at 3 and 6 months (each p < 0.001 vs. baseline) with no difference between the groups. Sites with initial PD ≥ 6 mm also improved in both groups after 3 and 6 months (p < 0.001) with a higher reduction of PD in the AMX/MET group (p < 0.05). T. forsythia was lower in the AMX/MET group after 3 months (p < 0.05). MMP-8 and IL-1β were without significant changes and differences between the groups. Conclusion: When A. actinomycetemcomitans was not detected in the subgingival biofilm, the adjunctive systemic use of amoxicillin/metronidazole results in better clinical and microbiological outcomes of non-surgical periodontal therapy when the application of systemic antibiotics is scheduled.
- 1 March 2015
- Published by Elsevier in Journal of Dentistry
- Vol. 43 (3) , 350-361
A three-year clinical evaluation of a one-step self-etch and a two-step etch-and-rinse adhesive in non-carious cervical lesions
- 1 March 2015
- Published by Elsevier in Journal of Dentistry
- Vol. 43 (3) , 350-361
A three-year clinical evaluation of a one-step self-etch and a two-step etch-and-rinse adhesive in non-carious cervical lesions
- 1 June 2013
- Vol. 15 (3) , 275-286
Experimental and Clinical Evaluation of a Self-etching and an Etch-and-Rinse Adhesive System
To assess the one-step self-etching adhesive iBond Gluma inside (1-SE) and the two-step etch-and rinse adhesive Gluma Comfort Bond (2-ER), both used in combination with the fine particle hybrid composite Venus, in a laboratory and in a prospective clinical study. In the in vitro study, tooth-composite interaction, microleakage, and adhesive failure of 8 Class V restorations per system were evaluated by light and scanning electron microscopy. In the in vivo study, 90 paired Class III/IV restorations were scored over 48 months (modified USPHS criteria). Cumulative failure rates (CFR) were calculated. In vitro, microleakage and adhesive failure at enamel margins were significantly increased with 1-SE in comparison with 2-ER. With 1-SE, micromechanical interlocking at enamel was reduced and pores within the adhesive layer arose. In vivo, after 48 months with 1-SE, decreased marginal integrity and an increased number of dark marginal color lines were observed. Because the results of the 4-year clinical study showed lower esthetics and marginal integrity for the 1-SE adhesive, its use should be viewed critically, which is in line with the reduced enamel-adhesive-composite interaction found in vitro.
- 1 June 2013
- Vol. 15 (3) , 275-286
Experimental and Clinical Evaluation of a Self-etching and an Etch-and-Rinse Adhesive System
To assess the one-step self-etching adhesive iBond Gluma inside (1-SE) and the two-step etch-and rinse adhesive Gluma Comfort Bond (2-ER), both used in combination with the fine particle hybrid composite Venus, in a laboratory and in a prospective clinical study. In the in vitro study, tooth-composite interaction, microleakage, and adhesive failure of 8 Class V restorations per system were evaluated by light and scanning electron microscopy. In the in vivo study, 90 paired Class III/IV restorations were scored over 48 months (modified USPHS criteria). Cumulative failure rates (CFR) were calculated. In vitro, microleakage and adhesive failure at enamel margins were significantly increased with 1-SE in comparison with 2-ER. With 1-SE, micromechanical interlocking at enamel was reduced and pores within the adhesive layer arose. In vivo, after 48 months with 1-SE, decreased marginal integrity and an increased number of dark marginal color lines were observed. Because the results of the 4-year clinical study showed lower esthetics and marginal integrity for the 1-SE adhesive, its use should be viewed critically, which is in line with the reduced enamel-adhesive-composite interaction found in vitro.